AGEN
Agenus Inc.NASDAQHealthcare$3.33-2.06%ClosedMarket Cap: $127.9M
As of 2026-04-06
Valuation
P/E (TTM)
1111.88
PEG
11.11
P/B
-0.49
P/S
1.27
EV/EBITDA
6.70
DCF Value
$-26.51
FCF Yield
-109.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
35.7%
Operating Margin
-17.7%
Net Margin
0.1%
ROE
-0.0%
ROA
0.1%
ROIC
-34.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $34.2M | 98.3% | $14.4M | $-10.6M | $-0.30 | — |
| FY 2025 | $114.2M | 90.3% | $-20.6M | $115.0K | $-0.00 | — |
| Q3 2025 | $30.2M | 19.8% | $-4.5M | $63.9M | $1.94 | — |
| Q2 2025 | $25.7M | -4.9% | $-16.7M | $-28.0M | $-1.00 | — |
| Q1 2025 | $24.1M | 10.0% | $-13.3M | $-25.3M | $-1.03 | — |
| Q4 2024 | $26.8M | -26.3% | $-25.9M | $-45.9M | $-2.04 | — |
| FY 2024 | $103.5M | -50.8% | $-120.5M | $-227.2M | $-10.59 | — |
| Q3 2024 | $25.1M | -64.1% | $-31.5M | $-66.4M | $-3.08 | — |
| Q2 2024 | $23.5M | -56.9% | $-30.2M | $-53.1M | $-2.52 | — |
| Q1 2024 | $28.0M | 87.6% | $-32.9M | $-61.9M | $-3.11 | — |
| Q4 2023 | $83.8M | 20.1% | $-4.2M | $-46.3M | $-2.48 | — |
| FY 2023 | $156.3M | -52.1% | $-159.5M | $-245.8M | $-13.75 | — |